Select Region

Mitsubishi Corporation has Offices & Subsidiaries in approximately 90 countries and regions worldwide

  • Japan (Head Office)
  • North America
  • Latin America & the Caribbean
  • Europe
  • Africa
  • Middle East
  • Central Asia
  • East Asia
  • Asia & Oceania
  • Japan (Head Office)
  • North America
  • Latin America &
    the Caribbean
  • Europe
  • Africa
  • Middle East
  • Central Asia
  • East Asia
  • Asia & Oceania

Japan (Head Office)

North America

Latin America & the Caribbean

Please see details of our activities in Latin America & the Caribbean here.

Corporate Brochure

Central Asia

Mitsubishi Corporation

Press Room

April 24, 2012

Mitsubishi Corporation to Expand its Product Portfolio for Medical Institutions
Acquiring 80% of Kobayashi Medical, Kobayashi Pharmaceutical's Medical Device Import and Distribution Company

Mitsubishi Corporation (“MC”) will strengthen its medical device import and distribution business by expanding its product offerings for medical institutions.  As part of this strategy, Mitsubishi Corporation has agreed today with Kobayashi Pharmaceutical to acquire 80% of Kobayashi Medical, a wholly-owned subsidiary of Kobayashi Pharmaceutical.
With the aging of society, companies involved in the medical field are increasingly seeking to offer safe medical devices to treat lifestyle diseases such as cancer as well as myocardial infarction, strokes, and bone fractures.
MC is involved in the import and distribution of medical devices through its group company, which mainly handles endoscopes and surgical instruments in minimally invasive surgery and urology.
Teaming up with Kobayashi Medical, which handles bone fracture treatment equipment and surgical instruments, will enable MC to offer a wider range of devices and products. In addition, MC is aiming to expand Kobayashi Medical’s business by leveraging MC’s global network and partnerships with its group companies.
Through the medical field business, Mitsubishi Corporation is working to create sustainable corporate value by contributing to economic and social development.
1. Summary of Kobayashi Medical
(1)Headquarters                    : 2-5-8 Imabashi, Chuo-ku, Osaka City, Osaka
(2)Establishment                   : April, 2010
(3)Capital               : 50 mil. JPY (As of March 31, 2011)
(4)Business                          : Import and distribution of medical devices
(5)Employees                        : 243 (As of March 31, 2011)
(6)Principal Shareholders       : 100% Kobayashi Pharmaceutical
(7)Representative   : President & CEO Hiroshi Kudo
2. Summary of Kobayashi Pharmaceutical
(1)Headquarters                    : 4-4-10 Doshomachi, Chuo-ku, Osaka City, Osaka
(2)Establishment                   : August, 1919
(3)Capital               : 3,450 mil. JPY (As of March 31, 2011)
(4)Business           : Manufacture and sales of pharmaceuticals, non-pharmaceuticals, deodorizers and sanitary supplies
(5)Revenue                          : 130.8 bil. JPY (As of 31, March, 2011)
(6)Employees                        : Consolidated 2.390/ Non-consolidated 1,040 (As of March 31, 2011)
(7)Representative   : President & CEO Yutaka Kobayashi
3.Summary of Mitsubishi Corporation
(1)Headquarters                    : 3-1, Marunouchi 2-Chome, Chiyoda-ku, Tokyo, 100-8086, Japan
(2)Establishment                   : July 1, 1954
(3)Capital               : 203,598 mil JPY(As of March 31, 2011)
(4)Business                        : Mitsubishi Corporation (MC) has six Business Groups which develop operations in the diverse fields of Industrial Finance, Logistics & Development, Energy, Metals, Machinery, Chemicals, and Living Essentials. In addition to these Business Groups, MC has also established the Business Service Group and Global Environment Business Development Group.
(5)Sales                               : 19,233 bil. JPY
(6)Employees                        : 58,470 (as of March 31, 2011)
(7)Representative                 : Ken Kobayashi, President and Chief Executive Officer

Inquiry Recipient

Mitsubishi Corporation
Telephone:+81-3-3210-2171 / Facsimile:+81-3-5252-7705